Editorial: Strategic molecular biomarkers and microRNAs in cancer.
作者信息
López-Camarillo César, Slaby Ondrej, Silva-Cázares Macrina Beatriz
机构信息
Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de Mexico, Mexico.
Molecular Oncology II-Solid Cancer Central European Institute of Technology, Brno, Czechia.
出版信息
Front Oncol. 2022 Oct 12;12:1031349. doi: 10.3389/fonc.2022.1031349. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Strategic molecular biomarkers and microRNAs in cancer.社论：癌症中的战略分子生物标志物与微小RNA
Front Oncol. 2022 Oct 12;12:1031349. doi: 10.3389/fonc.2022.1031349. eCollection 2022.
2
Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.用于前列腺癌转移的生物标志物 microRNAs：通过网络脆弱性分析模型筛选。
J Transl Med. 2018 May 21;16(1):134. doi: 10.1186/s12967-018-1506-7.
3
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.miRNAs 作为卵巢癌临床癌症生物标志物的作用：简要概述。
Cells. 2020 Jan 9;9(1):169. doi: 10.3390/cells9010169.
4
microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer.微小RNA表达作为肺癌早期预测和持续监测的新型遗传生物标志物
Biochem Genet. 2017 Aug;55(4):281-290. doi: 10.1007/s10528-016-9789-y. Epub 2017 Jan 9.
5
Statistical Methods for Identifying Biomarkers from miRNA Profiles of Cancers.从癌症的微小RNA谱中识别生物标志物的统计方法
Methods Mol Biol. 2019;1882:261-286. doi: 10.1007/978-1-4939-8879-2_24.
6
MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.miRNA 失调协同网络：在非小细胞肺癌的不同亚型中发现 miRNA 失调调控模块。
BMC Bioinformatics. 2018 Dec 21;19(Suppl 20):504. doi: 10.1186/s12859-018-2536-0.
7
MicroRNAs as cancer biomarkers.微小RNA作为癌症生物标志物
Microrna. 2013;2(2):102-17. doi: 10.2174/22115366113029990015.
8
Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.将血液和血浆中的微小RNA用作结直肠癌患者的非侵入性生物标志物
Clin Lab. 2018 Mar 1;64(3):257-262. doi: 10.7754/Clin.Lab.2017.170819.
9
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.循环 microRNAs 作为卵巢癌无创性生物标志物的评估：病例对照研究。
Arch Gynecol Obstet. 2022 Jul;306(1):151-163. doi: 10.1007/s00404-021-06287-1. Epub 2021 Dec 10.
10
Plasma exosome microRNAs are indicative of breast cancer.血浆外泌体微小RNA可作为乳腺癌的指示物。
Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.
引用本文的文献
1
Editorial: Host response to veterinary infectious diseases: role of coding and non-coding RNAs as biomarkers and disease modulators.社论：宿主对兽医传染病的反应：编码和非编码RNA作为生物标志物和疾病调节剂的作用
Front Vet Sci. 2023 Aug 29;10:1275169. doi: 10.3389/fvets.2023.1275169. eCollection 2023.
本文引用的文献
1
Editorial: The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory to Clinical Utility.社论：非编码RNA在实体瘤预后中的作用：从实验室到临床应用
Front Oncol. 2021 Feb 2;10:631316. doi: 10.3389/fonc.2020.631316. eCollection 2020.
2
Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples.分析和临床验证成对 microRNA 表达分析在甲状腺细针抽吸样本中识别甲状腺髓样癌的应用。
Cancer Cytopathol. 2021 Mar;129(3):239-249. doi: 10.1002/cncy.22365. Epub 2020 Oct 5.
3
Editorial: From "Junk DNA" to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs.社论：从“垃圾DNA”到用于癌症诊断、分期及个性化治疗的临床相关工具：非编码RNA的惊人案例
Front Oncol. 2019 May 14;9:389. doi: 10.3389/fonc.2019.00389. eCollection 2019.
4
MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.微小RNA表达及其对乳腺癌诊断和治疗策略的影响。
Cancer Treat Rev. 2009 Jun;35(4):328-34. doi: 10.1016/j.ctrv.2008.12.002. Epub 2009 Jan 25.
5
Non-coding RNA genes and the modern RNA world.非编码RNA基因与现代RNA世界
Nat Rev Genet. 2001 Dec;2(12):919-29. doi: 10.1038/35103511.
Zotero 插件